A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial FibrillationClinical Perspective

(2016) Jonas Oldgren et al.   CIRCULATION

Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial FibrillationCLINICAL PERSPECTIVE

(2016) Prateeti Khazanie et al.   Circulation-Heart Failure

Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation

(2016) Ziad Hijazi et al.   CLINICAL CHEMISTRY

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

(2016) Jean-Pierre Bassand et al.   EUROPEAN HEART JOURNAL

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

(2016) Ziad Hijazi et al.   EUROPEAN HEART JOURNAL

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation

(2016) Ziad Hijazi et al.   HEART

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

(2016) Ziad Hijazi et al.   LANCET

Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 Trial

(2016) Alon Eisen et al.   Journal of the American Heart Association

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

(2016) Sean D. Pokorney et al.   Journal of the American Heart Association

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

(2015) Karel G.M. Moons et al.   ANNALS OF INTERNAL MEDICINE

Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation

(2014) Lars Wallentin et al.   CIRCULATION

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

(2014) Craig T. January et al.   CIRCULATION

Comparison of Cardiac Troponins I and T Measured with High-Sensitivity Methods for Evaluation of Prognosis in Atrial Fibrillation: An ARISTOTLE Substudy

(2014) Z. Hijazi et al.   CLINICAL CHEMISTRY

Towards better clinical prediction models: seven steps for development and an ABCD for validation

(2014) E. W. Steyerberg et al.   EUROPEAN HEART JOURNAL

D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trial

(2014) C. Christersson et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

External validation of a Cox prognostic model: principles and methods

(2013) Patrick Royston et al.   BMC Medical Research Methodology

Causes of Death and Influencing Factors in Patients With Atrial Fibrillation

(2013) Eloi Marijon et al.   CIRCULATION

High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation

(2013) Ziad Hijazi et al.   CIRCULATION

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation

(2013) Ziad Hijazi et al.   CIRCULATION

Biomarkers in atrial fibrillation: a clinical review

(2013) Z. Hijazi et al.   EUROPEAN HEART JOURNAL

All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study

(2013) Tommy Andersson et al.   EUROPEAN HEART JOURNAL

N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

(2013) Ziad Hijazi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin

(2013) Ziad Hijazi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation

(2012) Ziad Hijazi et al.   CIRCULATION

Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials

(2011) G. Wells et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

(2010) Renato D. Lopes et al.   AMERICAN HEART JOURNAL

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

(2010) Anthony S.L. Tang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

(2009) Michael D. Ezekowitz et al.   AMERICAN HEART JOURNAL

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers

(2008) Andrew J Vickers et al.   BMC Medical Informatics and Decision Making

Cardiac Resynchronization in Patients With Atrial Fibrillation

(2008) Gaurav A. Upadhyay et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY